Is Seroquel (quetiapine) classified as a controlled substance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Seroquel (Quetiapine) a Controlled Substance?

No, Seroquel (quetiapine) is not classified as a controlled substance by the FDA. 1

Regulatory Classification

The FDA drug label explicitly states: "SEROQUEL is not a controlled substance" 1. This means quetiapine is not scheduled under the Controlled Substances Act (Schedule I-V), unlike benzodiazepines (Schedule IV) or other drugs with recognized abuse potential that require special prescribing restrictions 2.

Important Clinical Caveats

Despite not being controlled, quetiapine has documented abuse potential that clinicians must recognize:

  • The FDA label acknowledges: "SEROQUEL has not been systematically studied, in animals or humans, for its potential for abuse, tolerance, or physical dependence" and warns that "patients should be evaluated carefully for a history of drug abuse, and such patients should be observed closely for signs of misuse or abuse" 1

  • Real-world abuse patterns exist, particularly in correctional settings and among individuals with prior substance use history. Intravenous quetiapine abuse has been documented since 2005, with cases of diversion for recreational purposes 3

  • All documented abuse cases have involved patients with prior substance abuse history 3

Clinical Implications

Because quetiapine lacks controlled substance classification:

  • No special DEA prescribing requirements apply (unlike Schedule IV drugs like benzodiazepines or phentermine) 2, 4
  • Standard prescription monitoring is sufficient from a regulatory standpoint
  • However, clinical vigilance is warranted in patients with substance use disorders—monitor for drug-seeking behavior, dose escalation, and tolerance development 1

The non-controlled status may lead some clinicians to underestimate diversion risk, but the evidence clearly shows quetiapine can be misused, particularly by vulnerable populations 3, 5.

References

Research

Quetiapine: treatment for substance abuse and drug of abuse.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Research

Quetiapine: misuse and abuse.

Prescrire international, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.